Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

456 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Prognostic impact of the conditioning intensity on outcomes after allogeneic transplantation for MDS with low blasts: a nationwide retrospective study by the adult MDS working group of the Japan Society for Transplantation and Cellular Therapy.
Itonaga H, Miyazaki Y, Fujioka M, Aoki J, Doki N, Nishida T, Fukuda T, Uchida N, Ueda Y, Uehara Y, Katayama Y, Ota S, Kawakita T, Kato J, Matsuoka KI, Eto T, Onizuka M, Ichinohe T, Atsuta Y, Ishiyama K. Itonaga H, et al. Among authors: kawakita t. Bone Marrow Transplant. 2024 May 7. doi: 10.1038/s41409-024-02297-0. Online ahead of print. Bone Marrow Transplant. 2024. PMID: 38714756
Stress responses to bacterial and viral mimetics in polycystic ovary syndrome model rats.
Kamada S, Noguchi H, Yamamoto S, Tamura K, Aoki H, Takeda A, Uchishiba M, Minato S, Arata M, Arakaki R, Inui H, Kagawa T, Kawakita T, Yoshida A, Mineda A, Yamamoto Y, Kinouchi R, Yoshida K, Kaji T, Nishimura M, Iwasa T. Kamada S, et al. Among authors: kawakita t. Brain Behav Immun Health. 2024 Apr 9;38:100772. doi: 10.1016/j.bbih.2024.100772. eCollection 2024 Jul. Brain Behav Immun Health. 2024. PMID: 38650845 Free PMC article.
Allogeneic transplantation of bone marrow versus peripheral blood stem cells from HLA-identical sibling donors for hematological malignancies in 6064 adults from 2003 to 2020: different impacts on survival according to time period.
Konuma T, Miyao K, Nakasone H, Ouchi F, Fukuda T, Tanaka M, Ozawa Y, Ota S, Kawakita T, Uchida N, Sawa M, Katayama Y, Hiramoto N, Eto T, Ichinohe T, Atsuta Y, Kanda J; Donor/Source Working Group of the Japanese Society for Transplantation and Cellular Therapy. Konuma T, et al. Among authors: kawakita t. Cytotherapy. 2024 Mar 30:S1465-3249(24)00569-3. doi: 10.1016/j.jcyt.2024.03.489. Online ahead of print. Cytotherapy. 2024. PMID: 38639671
In Reply.
Onishi K, Huang JC, Kawakita T. Onishi K, et al. Among authors: kawakita t. Obstet Gynecol. 2024 May 1;143(5):e142-e143. doi: 10.1097/AOG.0000000000005561. Obstet Gynecol. 2024. PMID: 38636091 No abstract available.
A phase 1/2 study of NS-87/CPX-351 (cytarabine and daunorubicin liposome) in Japanese patients with high-risk acute myeloid leukemia.
Usuki K, Miyamoto T, Yamauchi T, Ando K, Ogawa Y, Onozawa M, Yamauchi T, Kiyoi H, Yokota A, Ikezoe T, Katsuoka Y, Takada S, Aotsuka N, Morita Y, Ishikawa T, Asada N, Ota S, Dohi A, Morimoto K, Imai S, Kishimoto U, Akashi K, Miyazaki Y; Study Group for NS-87/CPX-351. Usuki K, et al. Int J Hematol. 2024 Mar 26. doi: 10.1007/s12185-024-03733-z. Online ahead of print. Int J Hematol. 2024. PMID: 38532078
456 results